News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Daily News Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata Yael L. Maxwell October 09, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Conference News ESC 2023 FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF Shelley Wood August 28, 2023
News Daily News Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA L.A. McKeown July 11, 2023
News Daily News Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis Todd Neale June 05, 2023
News Daily News RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads Todd Neale January 19, 2023